Prevention and treatment of infections
AssigneeImmunoClin Limited
InventorsFrancisco Veas, Dorothee Misse, Mario Clerici, Daria Trabatoni
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of IL-22 in prevention and therapy of infections in particular related to viral infections in individuals who are unable to respond to viral exposure with enhanced IL-22 gene expression or protein production.
Claims14
1-8. (canceled)
12-13. (canceled)
The use of IL-22 to prevent or repair epithelial cell damages caused by pathogens to prevent pathogen adhesion to the mucosa and its subsequent crossing through the epithelium.
The use of IL-22 as a method to protect and repair epithelium barrier.
The use of IL-22 as a method to activate epithelial cells to produce proteins to prevent or treat infection.
Pharmaceutical compositions for preserving, protecting and repairing epithelium for prevention and treatment of infections.
Method to decrease MMP9 in infected tissues of individuals to protect and repair epithelium and therefore treat viral infections.
Dependencies are inferred from the claim text.